Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-25T14:06:27.488Z Has data issue: false hasContentIssue false
  • English
  • Français

Distribution of 1298A > C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia

Published online by Cambridge University Press:  16 April 2020

Bartosz Kempisty ,
Anna Bober ,
Marta Łuczak ,
Piotr Czerski ,
Aleksandra Szczepankiewicz ,
Joanna Hauser  and
Paweł P. Jagodziński
Bartosz Kempisty
Affiliation:
Department of Biochemistry and Molecular Biology, University of Medical Sciences, 6 Swiecickiego St., 60-781Poznan, Poland
Anna Bober
Affiliation:
Department of Biochemistry and Molecular Biology, University of Medical Sciences, 6 Swiecickiego St., 60-781Poznan, Poland
Marta Łuczak
Affiliation:
Department of Biochemistry and Molecular Biology, University of Medical Sciences, 6 Swiecickiego St., 60-781Poznan, Poland
Piotr Czerski
Affiliation:
Laboratory of Psychiatric Genetics, Department of Psychiatry, Poznan University of Medical Sciences, 27/33 Szpitalna St. 60-572Poznan, Poland
Aleksandra Szczepankiewicz
Affiliation:
Laboratory of Psychiatric Genetics, Department of Psychiatry, Poznan University of Medical Sciences, 27/33 Szpitalna St. 60-572Poznan, Poland
Joanna Hauser
Affiliation:
Laboratory of Psychiatric Genetics, Department of Psychiatry, Poznan University of Medical Sciences, 27/33 Szpitalna St. 60-572Poznan, Poland
Paweł P. Jagodziński*
Affiliation:
Department of Biochemistry and Molecular Biology, University of Medical Sciences, 6 Swiecickiego St., 60-781Poznan, Poland
*
*Corresponding author. Tel.: +48 (061)8546 513; fax: +48 (061)8546 510. E-mail address: [email protected] (P.P. Jagodziński).
Get access

Abstract

We investigated the genotype frequency of methylenetetrahydrofolate reductase (MTHFR) 1298A > C polymorphism in the group of patients with bipolar disorder type I (BDI) (n = 200) and schizophrenia (n = 200) and in the control group (n = 300). Odds ratio (OR) for patients with BD and schizophrenia in 1298CC homozygous state was 3.768 (95% CI = 1.752–8.104); P = 0.0003; (P = 0.0006 after Bonferroni correction) and 2.694; (95% CI = 1.207–6.013); P = 0.0123 (P = 0.0246 after Bonferroni correction), respectively. The stratification of patients based on gender revealed significant association of 1298CC genotype with female patients only with BDI (OR = 7.293; 95% CI = 2.017–26.363; P = 0.0005).

Our results confirm association of BD and schizophrenia with the 1p36.3 MTHFR locus and with the methyl group transfer using folate-dependent one-carbon pathway.

Keywords

Methylenetetrahydrofolate reductase (MTHFR)PolymorphismBipolar disorder I (BDI)Schizophrenia
Type
Genetic Epidemiology and Its Methods
Information
European Psychiatry , Volume 22 , Issue 1 , January 2007 , pp. 39 - 43
Copyright
Copyright © Elsevier Masson SAS 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andreoli, V.M., Maffei, F.Blood-levels of S-adenosylmethionine in schizophrenia. Lancet 1975;2:922.CrossRefGoogle Scholar
Anguelova, M., Benkelfat, C., Turecki, G.A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry 2003;7:646–653.CrossRefGoogle Scholar
Arinami, T., Yamada, N., Yamakawa-Kobayashi, K., Hamaguchi, H., Toru, M.Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 1997;74:526–528.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Badner, J.A., Gershon, E.S.Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002;7:405–411.CrossRefGoogle Scholar
Bakker, R.C., Brandjes, D.P.Hyperhomocysteinaemia and associated disease. Pharm World Sci 1997;3:126–132.CrossRefGoogle Scholar
Bottiglieri, T., Godfrey, P., Flynn, T., Carney, M.W., Toone, B.K., Reynolds, E.H.Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990;53:1096–1098.CrossRefGoogle ScholarPubMed
Cardno, A.G., Marshall, E.J., Coid, B., Macdonald, A.M., Ribchester, T.R., Davies, N.J.et al.Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999;56:162–168.CrossRefGoogle ScholarPubMed
Carlsson, A., Linquist, M.Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and norepinephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 1963;20:140.CrossRefGoogle Scholar
Craddock, N., Dave, S., Greening, J.Association studies of bipolar disorder. Bipolar Disord 2001;6:284–298.CrossRefGoogle Scholar
Craddock, N., Owen, M.Chromosomal aberrations and bipolar affective disorder. Br J Psychiatry 1994;164:507–512.CrossRefGoogle ScholarPubMed
Creveling, C.R.The role of catechol-O-methyltransferase in the inactivation of catecholestrogen. Cell Mol Neurobiol 2003;23:289–291.CrossRefGoogle ScholarPubMed
Crow, T.J.Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 1980;137:383.CrossRefGoogle ScholarPubMed
Curtis, D., Kalsi, G., Brynjolfsson, J., McInnis, M., O'Neill, J., Smyth, C.et al.Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23–q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr Genet 2003;13:77–84.CrossRefGoogle ScholarPubMed
DeLisi, L.E., Mesen, A., Rodriguez, C., Bertheau, A., LaPrade, B., Llach, M.et al.Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica. Am J Med Genet 2002;114:497–508.CrossRefGoogle Scholar
Ewald, H., Flint, T., Kruse, T.A., Mors, O.A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosome 1p22–21, 4p16, 6q14–22, 10q26 and 16p13.3. Mol Psychiatry 2002;7:734–744.CrossRefGoogle ScholarPubMed
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, D.C: American Psychiatric Press, Inc; 1996.Google Scholar
Freeman, J.M., Finkelstein, J.D., Mudd, S.H.Folate-responsive homocystinuria and “schizophrenia”. A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity. N Engl J Med 1975;292:491–496.CrossRefGoogle ScholarPubMed
Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G.et al.A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111–113.CrossRefGoogle ScholarPubMed
Godfrey, P.S., Toone, B.K., Carney, M.W., Flynn, T.G., Bottiglieri, T., Laundy, M.et al.Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990;336:392–395.CrossRefGoogle ScholarPubMed
Han, D.H., Kee, B.S., Min, K.J., Lee, Y.S., Na, C., Park, D.B.et al.Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Neuroreport 2006;17:195–199.CrossRefGoogle ScholarPubMed
Kempisty, B., Mostowska, A., Gorska, I., Luczak, M., Czerski, P., Szczepankiewicz, A.et al.Association of 677C > T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia. Neurosci Lett 2006;400:267–271.CrossRefGoogle Scholar
Kirov, G., O'Donovan, M.C., Owen, M.J.Finding schizophrenia genes. J Clin Invest 2005;115:1440–1448.CrossRefGoogle ScholarPubMed
Kohn, Y., Danilovich, E., Filon, D., Oppenheim, A., Karni, O., Kanyas, K.et al.Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: findings from identity by descent haplotype sharing analysis. Am J Med Genet B Neuropsychiatr Genet 2004;128:65–70.CrossRefGoogle Scholar
Kunugi, H., Fukuda, R., Hattori, M., Kato, T., Tatsumi, M., Sakai, T.et al.C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 1998;3:435–437.CrossRefGoogle ScholarPubMed
Lewis, C.M., Levinson, D.F., Wise, L.H., DeLisi, L.E., Straub, R.E., Hovatta, I.et al.Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003;73:34–38.CrossRefGoogle ScholarPubMed
Maier, W., Hofgen, B., Zobel, A., Rietschel, M.Genetic models of schizophrenia and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2005;255:159–166.CrossRefGoogle ScholarPubMed
Mamdani, F., Jaitovich-Groisman, I., Alda, M., Turecki, G.Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications. Curr Psychiatry Rep 2003;5:484–492.CrossRefGoogle ScholarPubMed
Matsushita, S., Muramatsu, T., Arai, H., Matsui, T., Higuchi, S.The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population. Am J Hum Genet 1997;61:1459–1460.CrossRefGoogle ScholarPubMed
Michelon, L., Vallada, H.Genetics of bipolar disorder. Rev Bras Psiquiatr 2004;(Suppl 3):12–16.CrossRefGoogle ScholarPubMed
Muntjewerff, J.W., Kahn, R.S., Blom, H.J., den Heijer, M.Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry Sep 20 2005 [Epub ahead of print].Google Scholar
Murray, R.M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., McDonald, C.A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 2004;71:405–416.CrossRefGoogle ScholarPubMed
Ohnishi, T., Hashimoto, R., Mori, T., Nemoto, K., Moriguchi, Y., Iida, H.et al.The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 2006;129:399–410.CrossRefGoogle ScholarPubMed
Olney, J.W.Role of excitotoxins in developmental neuropathology. APMIS 1993;(Suppl 40):103–112.Google ScholarPubMed
Pasquier, F., Lebert, F., Petit, H., Zittoun, J., Marquet, J.Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry 1994;57:765–766.CrossRefGoogle Scholar
Regland, B.Schizophrenia and single-carbon metabolism. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1124–1132.CrossRefGoogle ScholarPubMed
Regland, B., Johansson, B.V., Gottfries, C.G.Homocysteinemia and schizophrenia as a case of methylation deficiency. J Neural Transm Gen Sect 1994;98:143–152.CrossRefGoogle ScholarPubMed
Reif, A., Pfuhlmann, B., Lesch, K.P.Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog Neuropsychopharmacol Biol Psychiatry 2005;7:1162–1168.CrossRefGoogle Scholar
Sazci, A., Ergul, E., Kucukali, I., Kara, I., Kaya, G.Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1113–1123.CrossRefGoogle Scholar
Shifman, S., Bronstein, M., Sternfeld, M., Pisante, A., Weizman, A., Reznik, I.et al.COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004;128:61–64.CrossRefGoogle Scholar
Swann, A.C., Geller, B., Post, R.M., Altshuler, L., Chang, K.D., Delbello, M.P.et al.Practical clues to early recognition of bipolar disorder: a primary care approach, prim care companion. J Clin Psychiatry 2005;7:15–21.Google Scholar
Tan, E.C., Chong, S.A., Lim, L.C., Chan, A.O., Teo, Y.Y., Tan, C.H.et al.Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet 2004;14:227–231.CrossRefGoogle ScholarPubMed
Van der Put, N.M., Gabreels, J., Stevens, F., Smeitink, E.M.B., Trijbels, J.A.M., Eskes, F.J.M.et al.A second mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044–1051.CrossRefGoogle ScholarPubMed
Vilella, E., Virgos, C., Murphy, M., Martorell, L., Valero, J., Simo, J.M.et al.Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia. Prog Neuropsychopharmacol Biol Psych 2005;29:1169–1174.CrossRefGoogle ScholarPubMed
Weinberger, D.R.Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660–669.CrossRefGoogle ScholarPubMed
Zintzaras, E.C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet 2006;6:105–115.CrossRefGoogle Scholar
Zintzaras, E., Ioannidis, J.P.Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 2005;28:123–137.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.